Please login to the form below

Not currently logged in


This page shows the latest Synergy news and features for those working in and with pharma, biotech and healthcare.

Regeneron and Bluebird sign $100m cell therapies deal

Regeneron and Bluebird sign $100m cell therapies deal

Yancopoulos, M.D., Ph.D., president and chief scientific officer of Regeneron. “We believe that the tremendous synergies between Regeneron’s proven technologies and bluebird’s toolbox of advanced cell and

Latest news

More from news
Approximately 8 fully matching, plus 140 partially matching documents found.

Latest Intelligence

More from intelligence
Approximately 0 fully matching, plus 35 partially matching documents found.

Latest appointments

More from appointments
Approximately 1 fully matching, plus 9 partially matching documents found.

Latest from PMHub

More from PMHub
Approximately 20 fully matching, plus 48 partially matching documents found.

Featured jobs

Subscribe to our email news alerts


Add my company
Aptus Health

Aptus Health is dedicated to advancing health engagement. The company offers end-to-end digital health engagement solutions spanning all areas of...

Latest intelligence

The gene therapy revolution
Gene therapies are bringing new hope for many people with diseases caused by genetic disorders...
PM Society Digital Awards – the power of together
Our chief executive, Emma Statham, writes about the value of awards and the power of together....
Seduce anyone in four simple steps
You know the health of the global economy is dependent on our ability to seduce one another – don’t you? And you know that we need to be able to...